about
Paediatric pharmacokinetics and drug dosesApproaches for assessing risks to sensitive populations: lessons learned from evaluating risks in the pediatric populationUnderstanding and applying pharmacometric modelling and simulation in clinical practice and researchTesting new drugs in naked apes and getting the dose right in their youngExtrapolation of efficacy and other data to support the development of new medicines for children: A systematic review of methods.Sex- and age-related chemotherapy toxicity in patients with non-metastatic osteosarcoma.Age-related differences in susceptibility to cisplatin-induced renal toxicity.Tips and traps analyzing pediatric PK data.The European paediatric legislation: benefits and perspectives.Generation of novel pharmacogenomic candidates in response to methotrexate in juvenile idiopathic arthritis: correlation between gene expression and genotype.Pediatric phase II trials of poly-ICLC in the management of newly diagnosed and recurrent brain tumors.The medicines for children agenda in the UK.Neonatal seizures: controversies and challenges in translating new therapies from the lab to the isolette.Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and ChildrenPharmacogenetics and paediatric drug development: issues and consequences to labelling and dosing recommendations.Children in clinical trials: survey on the current situation in paediatric university clinics in GermanyThe utility of a rodent model in detecting pediatric drug-induced nephrotoxicity.The role of population PK-PD modelling in paediatric clinical research.Pharmacogenomics and active surveillance for serious adverse drug reactions in children.Pediatric pharmacogenetic and pharmacogenomic studies: the current state and future perspectives.Integration of pharmacogenetics and pharmacogenomics in drug development: implications for regulatory and medical decision making in pediatric diseases.Therapeutic misconception: hope, trust and misconception in paediatric research.Physiologically based pharmacokinetic (PBPK) modeling in children.Understanding dosing: children are small adults, neonates are immature children.Pharmacokinetics and pharmacokinetic-pharmacodynamic relationships of monoclonal antibodies in children.Prediction of drug clearance in children: a review of different methodologies.Neonatal medicines research: challenges and opportunities.Efficacy, safety and drug survival of conventional agents in pediatric psoriasis: A multicenter, cohort study.Explaining the acetaminophen-ibuprofen analgesic interaction using a response surface model.Adverse Drug Reactions in Hospitalized Pediatric Patients: A Prospective Observational Study."Bonne Année", "Gutes Neues Jahr"? Will 2007 be a "Happy New Year" for children's medicines in Europe?Money makes the world go round: the pervasiveness of pharmacoeconomics.Comparison of ketamine and ketofol for deep sedation and analgesia in children undergoing laser procedure.Performing a preliminary hazard analysis applied to administration of injectable drugs to infants.Why is there no morphine concentration-response curve for acute pain?2015 Meeting of the National Directors of Graduate Studies in Pharmacology and Physiology.
P2860
Q28078794-EF34C8F8-921F-48C8-A3B3-D2AFB47716B8Q28389663-869A5DBB-3F4F-4449-A958-2AE9B1775C70Q28468334-9979BA5D-99EF-4B5E-8582-06D688AA22D9Q28748959-F755BD56-32D4-4E91-B3C1-E563B5107BE0Q31060832-01471207-E2EC-41AC-8D2D-9F63BF897F7CQ33384413-90CFB838-085F-48D8-AC5B-353EC692A4E4Q33691277-280BE0A8-8573-4298-825A-C91304959EBBQ33820152-A521B9B2-27AD-4D0D-84DF-511D5D23E732Q34105078-A5471652-D4C7-44D5-8775-D2EFC1274246Q34235121-B9588CFD-4923-427C-B366-E8CAFDF2B86AQ35167156-E37F0439-453E-4AD9-BB49-3C930AF515A8Q35827708-A3A40E66-D1A3-4AE6-8447-6B47B6B9EEBAQ36059847-D4A95133-27B8-4984-A128-5461815C0109Q36322918-B62A84FB-66C9-4E7C-8602-5E96425FE445Q36909252-C4F00F33-5BE0-492C-B308-40BFED4E133AQ37244138-C7E97F6F-9D01-4ACE-A92E-576C0CD5F967Q37311830-A726C016-6EE3-46F0-98BB-5070D230B75BQ37719346-7C167EC8-A063-41D9-9753-B4D2A736D3A7Q37791154-2470D5C2-1BFE-454D-91C9-C6315D948286Q37808658-177AD6E4-8C2F-440D-8D65-7A960BA1E9FAQ37874869-048BB100-CD29-4B11-BC27-76D27B1802DAQ37986596-70DE3B58-6356-40B5-9D30-2CBE15CD7DD3Q38016332-4BA8D3C7-BCD2-4DE9-B690-A7D6D68590BBQ38119839-AF21A3C3-926E-4C59-8637-549986E1AEE0Q38291356-9FBF6375-5552-4A6C-8EA2-C7DACCD47E30Q38367747-7A0F663F-9C80-4197-B6DE-697AC70B0660Q38469763-543F0184-F0E1-4422-BDEE-2E0BDE9BD43EQ39108777-6CE006C9-990C-498C-B3C9-B7F4FF39C81AQ39733241-5C3C9AA9-F9C0-4031-A47B-18CFB952954EQ39967338-18231EE8-1667-4CC2-9088-2D43503BE79CQ40307613-3147451A-CF63-469D-A740-B85777B3E67FQ43137171-B9A99BAE-FE7B-4316-8474-4942F9DBD52EQ47273944-FF2C1488-FB48-4ABF-83B6-521310C77CD3Q48192870-0F063523-054B-4E21-904C-F3959B3E18CDQ51119182-ACD161FF-61A6-4E7F-9E65-100EB1F64602Q55420470-CFC56291-955A-4AA1-B618-877860CB86E3
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
How children's responses to drugs differ from adults.
@ast
How children's responses to drugs differ from adults.
@en
type
label
How children's responses to drugs differ from adults.
@ast
How children's responses to drugs differ from adults.
@en
prefLabel
How children's responses to drugs differ from adults.
@ast
How children's responses to drugs differ from adults.
@en
P2860
P1476
How children's responses to drugs differ from adults.
@en
P2093
Terence Stephenson
P2860
P304
P356
10.1111/J.1365-2125.2005.02445.X
P407
P577
2005-06-01T00:00:00Z